Fresenius Medical Care AG & Co. KGaA

(NYSE:FMS)

Latest On Fresenius Medical Care AG & Co. KGaA (FMS):

Date/Time Type Description Signal Details
2024-05-17 05:58 ESTDividendA dividend of $0.63 has been announced on Apr 15, 2024. It will be paid Jun 3, 2024 with an ex-dividend date of May 17, 2024.Neutral
2023-05-26 04:49 ESTNewsFresenius sees brighter days for pharma division KabiN/A
2023-05-17 05:57 ESTDividendA dividend of $0.62 has been announced on May 3, 2023. It will be paid Jun 1, 2023 with an ex-dividend date of May 17, 2023.Neutral
2023-05-09 21:01 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 06:47 ESTNewsFresenius Q1 operating income drop softened by easing labor shortage; deconsolidation on trackN/A
2023-03-21 13:10 ESTNewsFresenius Medical Care: Attractive Post Crash, Maintaining A 'Buy' RatingN/A
2023-02-22 20:16 ESTNewsFresenius Medical Care AG & Co. KGaA 2022 Q4 - Results - Earnings Call PresentationN/A
2023-02-22 20:16 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) Q4 2022 Earnings Call TranscriptN/A
2023-02-22 07:16 ESTNewsFresenius stock rises as Q4 revenue grows, plans restructuring; sees 'headwinds' in FY23N/A
2023-02-21 18:45 ESTNewsFresenius Medical Care Q4 2022 Earnings PreviewN/A
2023-02-09 18:36 ESTNewsFresenius considering deconsolidating dialysis subsidiary - BloombergN/A
2023-01-06 19:18 ESTNewsFresenius: The Company Is Climbing, And I'm At 'Buy'N/A
2022-12-06 11:18 ESTNewsFresenius Medical Care CFO takes over as CEO amid focus on 'operational turnaround'N/A
2022-11-01 02:52 ESTNewsFresenius under pressure to make changes as activist Elliott takes 3% stake - BloombergN/A
2022-11-01 02:52 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) Q3 2022 Earnings Call TranscriptN/A
2022-10-31 10:36 ESTNewsFresenius Q3 net income falls amid labor market woes, cuts FY22 outlook on slower recoveryN/A
2022-10-31 10:35 ESTNewsFresenius Medical Care AG & Co. KGaA 2022 Q3 - Results - Earnings Call PresentationN/A
2022-10-27 18:07 ESTNewsFresenius: A Contrarian Opportunity Not Seen For 20 Years (Technical Analysis)N/A
2022-10-19 18:05 ESTNewsFresenius Medical gains after report of activist Elliott stake in Fresenius SEN/A
2022-10-10 19:51 ESTNewsFresenius cut to Hold at Jefferies citing staffing issues and inflationN/A
2022-08-31 05:50 ESTNewsFresenius gets award to provide dialysis services to U.S. military veteransN/A
2022-08-21 01:47 ESTNewsFresenius appoints head of pharma unit as new CEON/A
2022-08-19 05:43 ESTNewsFresenius: Too Cheap, Measured By Sum-Of-The-PartsN/A
2022-07-30 11:07 ESTNewsFresenius Medical Care: Best Time In 21 Years To Buy This High-Yield Dividend AristocratN/A
2022-07-28 17:20 ESTNewsFresenius stock slumps 13% as labor costs, inflation impact leads to FY22 outlook cut; 2025 targets withdrawnN/A
2022-07-14 00:09 ESTNewsFresenius slips as U.S. joins whistleblower lawsuit over Medicare fraudN/A
2022-06-19 10:01 ESTNewsFresenius: Revisiting The Thesis - Still A BuyN/A
2022-05-13 05:58 ESTDividendA dividend of $0.71 has been announced on Apr 28, 2022. It will be paid May 27, 2022 with an ex-dividend date of May 13, 2022.Neutral
2022-05-04 16:46 ESTNewsFresenius Medical Care Non-GAAP EPS of €0.68, revenue of €4.55BN/A
2022-05-04 16:46 ESTNewsFresenius Medical Care AG & Co. (FMS) CEO Rice Powell on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 00:06 ESTNewsFresenius Medical names Carla Kriwet as next CEON/A
2022-05-02 12:10 ESTNewsFresenius: The Upside Is Getting BiggerN/A
2022-03-31 22:53 ESTNewsFresenius Kabi bolsters biosimilar, infusion businesses with mAbxience and Ivenix dealsN/A
2022-02-23 09:19 ESTNewsFresenius Medical Care AG & Co. KGaA. (FMS) CEO Rice Powell on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-22 14:15 ESTNewsFresenius Medical Care Non-GAAP EPS of €0.90, revenue of €4.64BN/A
2022-02-09 23:34 ESTNewsFresenius Medical Care: World Leader In Dialysis, But Still Not ExcitingN/A
2021-12-01 13:22 ESTNewsFresenius Medical Care announces company reorganizationN/A
2021-11-08 23:21 ESTNewsFresenius Medical Care reports Q3 resultsN/A
2021-11-03 03:44 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q3 2021 Results - Earnings Call TranscriptN/A
2021-09-22 13:49 ESTNewsFresenius Medical Care partners with JMS to advance home dialysis in JapanN/A
2021-09-10 12:19 ESTNewsFresenius Medical Care stock falls ~4% amid JPMorgan downgrade on COVID impactN/A
2021-08-28 14:57 ESTNewsYou Really Want To Know About Fresenius Medical CareN/A
2021-07-31 01:01 ESTNewsFresenius Medical Care AG & Co. KGaA 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-31 01:00 ESTNewsFresenius Medical Care AG & Co. KGaA (FMS) CEO Rice Powell on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-30 05:41 ESTNewsFresenius Medical Care misses on revenueN/A
2021-05-24 05:59 ESTDividendA dividend of $0.83 has been announced on Nov 30, -0001. It will be paid Jun 7, 2021 with an ex-dividend date of May 24, 2021.Neutral
2021-03-18 23:24 ESTAnalyst RatingThe Analyst Target Price has increased from $37.49 to $37.74.Buy
2021-03-17 22:28 ESTAnalyst RatingThe Analyst Target Price has decreased from $37.56 to $37.49.Neutral
2021-03-17 14:31 ESTAnalyst RatingThe Analyst Target Price has decreased from $37.65 to $37.56.Neutral
2021-03-17 13:39 ESTNewsFresenius Medical Care Appears To Be Fairly ValuedN/A

About Fresenius Medical Care AG & Co. KGaA (FMS):

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

See Advanced Chart

General

  • Name Fresenius Medical Care AG & Co. KGaA
  • Symbol FMS
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Care Facilities
  • Full Time Employees 125,364
  • Last Split Factor2:1
  • Last Split Date2012-12-04
  • Fiscal Year EndDecember
  • IPO Date1996-09-19
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Providers & Services
  • Gic SubIndustryHealth Care Services
  • Web URLhttp://www.freseniusmedicalcare.com
View More

Valuation

  • Trailing PE 9.88
  • Forward PE 13.18
  • Price/Sales (Trailing 12 Mt.) 1.01
  • Price/Book (Most Recent Quarter) 1.6
  • Enterprise Value Revenue 1.94
  • Enterprise Value EBITDA 8.4
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $2.16
  • Next Year EPS Estimate $2.40
  • Next Quarter EPS Estimate $0.69
  • Profit Margin 7%
  • Return on Assets 5%
  • Return on Equity 11%
  • Earnings Per Share $3.69
  • Revenue Per Share $0
  • Gross Profit 5.54 billion
  • Quarterly Earnings Growth -3.9%
View More

Highlights

  • Market Capitalization 21.37 billion
  • PEG Ratio 2.23
  • Analyst Target Price $37.74
  • Book Value Per Share $21.29
View More

Share Statistics

  • Shares Outstanding 585.75 million
  • Shares Float 396.99 million
  • % Held by Insiders <1%
  • % Held by Institutions 1.63%
  • Shares Short 995926
  • Shares Short Prior Month 360804
  • Short Ratio 1.42
View More

Technicals

  • Beta 0.96
  • 52 Week High $45.78
  • 52 Week Low $28.69
  • 50 Day Moving Average 36.07
  • 200 Day Moving Average 40.4
View More

Dividends

  • Forward Annual Dividend Rate $0.72
  • Forward Annual Dividend Yield 1.96%
  • Payout Ratio 26%
  • Dividend Date 2020-09-11
  • ExDividend Date 2020-08-28
  • Dividend Per Share $1.24
  • Dividend Yield 3.32%
View More

Fresenius Medical Care AG & Co. KGaA (FMS) Dividend Calendar:

Fresenius Medical Care AG & Co. KGaA pays an annual dividend of $0.72 per share, with a dividend yield of 3.32%.
FMS's last dividend payment was made to shareholders on September 11, 2020.
Fresenius Medical Care AG & Co. KGaA pays out 26% of its earnings out as a dividend.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Fresenius Medical Care AG & Co. KGaA (FMS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-23$N/A$0.77$0.80-3.85%
2020-09-302020-10-29$4.41 billion$0.71$0.6411.1%
2020-06-302020-07-30$4.56 billion$0.71$0.5431.36%
2020-03-312020-05-06$N/A$0.51$0.63-18.4%
2019-12-312020-02-20$5.14 billion$0.73$0.696.67%
2019-09-302019-10-29$4.82 billion$0.61$0.61-0.52%
2019-06-302019-07-30$4.9 billion$0.51$0.55-6.36%
2019-03-312019-05-02$4.63 billion$0.58$0.5114.34%
2018-12-312019-02-20$4.93 billion$0.65$0.65-0.14%
2018-09-302018-10-30$4.7 billion$0.57$0.64-10.2%
2018-06-302018-07-31$4.9 billion$0.52$0.62-16.54%
2018-03-312018-05-03$4.89 billion$0.48$0.61-21.61%
2017-12-312018-02-26$5.6 billion$0.73$0.6610.21%
2017-09-302017-11-02$5.48 billion$0.61$0.62-1.93%
2017-06-302017-08-01$5.43 billion$0.53$0.512.61%
2017-03-312017-05-03$4.87 billion$0.44$0.441.42%
2016-12-312017-02-22$4.69 billion$0.61$0.62-2.01%
2016-09-302016-10-27$4.6 billion$0.55$0.524.81%
2016-06-302016-08-01$4.42 billion$0.48$0.49-2.44%
2016-03-312016-05-03$4.21 billion$0.37$0.42-11.38%
2015-12-312016-02-24$4.35 billion$0.57$0.58-1.63%
2015-09-302015-10-29$4.23 billion$0.43$0.46-6.52%
2015-06-302015-07-30$4.2 billion$0.40$0.42-4.76%
2015-03-312015-04-29$3.96 billion$0.35$0.39-10.26%
2014-12-312015-02-25$4.32 billion$0.55$0.4912.24%
2014-09-302014-11-04$4.11 billion$0.45$0.442.27%
2014-06-302014-07-31$3.83 billion$0.42$0.412.44%
2014-03-312014-05-06$3.56 billion$0.34$0.38-10.53%
2013-12-312014-02-25$3.87 billion$0.59$0.5311.32%
2013-09-302013-11-05$3.67 billion$0.48$0.464.35%
2013-06-302013-07-30$3.61 billion$0.43$0.45-4.44%
2013-03-312013-04-30$3.46 billion$0.37$0.43-13.95%
2012-12-312013-02-26$3.71 billion$0.54$0.515.88%
2012-09-302012-10-31$3.42 billion$0.44$0.49-10.2%
2012-06-302012-08-01$3.43 billion$0.46$0.460%
2012-03-312012-05-03$3.25 billion$0.40$0.392.56%
2011-12-312012-02-21$3.26 billion$0.51$0.52-1.92%
2011-09-302011-11-02$3.18 billion$0.46$0.47-2.13%
2011-06-302011-08-02$3.14 billion$0.43$0.430%
2011-03-312011-05-04$2.98 billion$0.37$0.38-2.63%
2010-12-312011-02-23$3.17 billion$0.45$0.442.27%
2010-09-302010-11-02$3.06 billion$0.41$0.42-2.38%
2010-06-302010-08-03$2.95 billion$0.42$0.405%
2010-03-312010-05-04$2.88 billion$0.35$0.37-5.41%
2009-12-312010-02-24$3.04 billion$0.41$0.395.13%
2009-09-302009-11-03$2.89 billion$0.38$0.372.7%
2009-06-302009-08-04$2.76 billion$0.37$0.370%
2009-03-312009-04-30$2.56 billion$0.34$0.340%
2008-12-312009-02-19$2.72 billion$0.36$0.360%
2008-09-302008-11-04$2.71 billion$0.35$0.342.94%
2008-06-302008-07-30$2.67 billion$0.36$0.339.09%
2008-03-312008-04-30$2.51 billion$0.32$0.313.23%
2007-12-312008-02-20$2.57 billion$0.34$0.319.68%
2007-09-302007-10-30$2.43 billion$0.31$0.303.33%
2007-06-302007-08-02$2.4 billion$0.30$0.293.45%
2007-03-312007-05-02$2.32 billion$0.27$0.270%
2006-12-312007-02-22$2.35 billion$0.26$0.260%
2006-09-302006-10-31$2.23 billion$0.24$0.234.35%
2006-06-302006-08-03$2.17 billion$0.22$0.26-15.38%
2006-03-312006-05-03$1.75 billion$0.20$0.195.26%
2005-12-312006-02-22$1.77 billion$0.19
2005-09-302005-11-03$1.72 billion$0.20$0.200%
2005-06-302005-08-04$1.67 billion$0.20$0.200%
2005-03-312005-05-03$1.61 billion$0.19$0.20-5%
2004-12-312005-02-24$1.64 billion$0.19$0.20-5%
2004-09-302004-11-02$1.58 billion$0.18$0.18-1.83%
2004-06-302004-08-04$1.55 billion$0.17
2004-03-312004-05-06$1.46 billion$0.17
2003-12-312004-02-26$1.45 billion$0.17
2003-09-302003-11-04$1.41 billion$0.15
2003-06-302003-08-05$1.37 billion$0.15
2003-03-312003-05-07$1.3 billion$0.13
2002-12-312003-02-25$1.36 billion$0.14$0.137.69%
2002-09-302002-10-29$1.29 billion$0.12$0.120%
2002-06-302002-07-30$1.25 billion$0.13$0.130%
2002-03-312002-04-30$1.19 billion$0.13$0.14-7.14%
2001-12-312002-03-05$1.27 billion$0.11$0.110%
2001-09-302001-10-30$1.23 billion$0.11$0.12-8.33%
2001-06-302001-07-31$1.2 billion$0.11$0.110%
2001-03-312001-05-03$1.16 billion$0.10$0.11-9.09%
2000-12-312001-01-01$1.08 billion$0.11$0.110%
2000-09-302000-12-31$1.08 billion$0.11$0.110%
2000-06-302000-07-01$1.04 billion$0.10$0.11-9.09%
2000-03-312000-06-30$1 billion$0.10$0.11-9.09%
1999-09-301999-11-23$0.10$0.0911.11%
1999-06-301999-08-03$0.09$0.0812.5%
1999-03-311999-03-31$0.08
1998-12-311999-03-29$0.07$0.070%
1998-06-301998-07-23$0.04$0.06-33.33%
1997-09-301997-11-25$0.04$0.05-20%
1997-06-301997-08-27$0.07$0.070%
1997-03-311997-05-15$0.06$0.09-33.33%

Fresenius Medical Care AG & Co. KGaA (FMS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Fresenius Medical Care AG & Co. KGaA (FMS) Chart:

Fresenius Medical Care AG & Co. KGaA (FMS) News:

Below you will find a list of latest news for Fresenius Medical Care AG & Co. KGaA (FMS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Fresenius Medical Care AG & Co. KGaA (FMS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1750CALL0 0428.52TRUE00
2025-04-177.50CALL0 0322.78TRUE00
2025-04-17100CALL0 0398TRUE00
2025-04-1712.50CALL0 0320.84TRUE00
2025-04-17150CALL0 0249.36TRUE00
2025-04-1717.50CALL0 0196.67TRUE00
2025-04-17204.4CALL0 8151.83TRUE00
2025-04-1722.51.81CALL0 36954.66TRUE00
2025-04-17250.7CALL34 28936.22FALSE0.70
2025-04-17300.43CALL0 458.93FALSE00
2025-04-17350.15CALL0 3132.4FALSE00
2025-04-1750PUT0 0715.34FALSE00
2025-04-177.50PUT0 0533.73FALSE00
2025-04-17100PUT0 0417.75FALSE00
2025-04-1712.50PUT0 0332.1FALSE00
2025-04-17150.35PUT0 22263.41FALSE00
2025-04-1717.50.8PUT0 2205.07FALSE00
2025-04-17200.16PUT0 36152.99FALSE00
2025-04-1722.50.2PUT0 13751.41FALSE00
2025-04-17252.44PUT0 222.75TRUE00
2025-04-17300PUT0 098.32TRUE00
2025-04-17350PUT0 0137.29TRUE00
2025-05-1612.50CALL0 0166.94TRUE00
2025-05-16150CALL0 0159.96TRUE00
2025-05-1617.50CALL0 093.25TRUE00
2025-05-16200CALL0 089.49TRUE00
2025-05-1622.50CALL0 053.46TRUE00
2025-05-16250CALL0 062.79FALSE00
2025-05-16300CALL0 091.75FALSE00
2025-05-16350CALL0 0119.73FALSE00
2025-05-1612.50PUT0 0222.92FALSE00
2025-05-16150PUT0 0179.93FALSE00
2025-05-1617.50PUT0 0140.99FALSE00
2025-05-16200PUT0 072.85FALSE00
2025-05-1622.50PUT0 079.97FALSE00
2025-05-16251.5PUT0 161.57TRUE00
2025-05-16300PUT0 0112.03TRUE00
2025-05-16350PUT0 0143.6TRUE00
2025-07-1812.513.5CALL1 0144.67TRUE13.50
2025-07-181511CALL1 0114.5TRUE110
2025-07-1817.50CALL0 076.69TRUE00
2025-07-18205.1CALL0 248.97TRUE00
2025-07-1822.53.85CALL0 10437.86TRUE00
2025-07-18251.4CALL0 5726.53FALSE00
2025-07-18301CALL0 3551.22FALSE00
2025-07-1812.50.25PUT0 1154.51FALSE00
2025-07-18150.1PUT0 1123.18FALSE00
2025-07-1817.50PUT0 096.73FALSE00
2025-07-18201.1PUT0 476.83FALSE00
2025-07-1822.52.4PUT0 137.36FALSE00
2025-07-18252.31PUT0 24443.11TRUE00
2025-07-18306.8PUT0 137.83TRUE00
2025-10-1712.50CALL0 0104.34TRUE00
2025-10-17159.5CALL0 078.03TRUE00
2025-10-1717.50CALL0 061.11TRUE00
2025-10-17205.24CALL0 644.76TRUE00
2025-10-1722.53.8CALL0 35443.44TRUE00
2025-10-17250CALL0 029.81FALSE00
2025-10-17300CALL0 056.72FALSE00
2025-10-17350CALL0 067.89FALSE00
2025-10-1712.50PUT0 0121.73FALSE00
2025-10-17150PUT0 086.15FALSE00
2025-10-1717.50PUT0 079.69FALSE00
2025-10-17200PUT0 064.51FALSE00
2025-10-1722.52.25PUT0 347.32FALSE00
2025-10-17250PUT0 034.74TRUE00
2025-10-17300PUT0 030.6TRUE00
2025-10-17350PUT0 032.38TRUE00

Latest FMS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST23$26.55
Jun 13, 2022 7:59 PM EST13$26.565
Jun 13, 2022 7:59 PM EST100$26.585
Jun 13, 2022 7:59 PM EST100$26.585
Jun 13, 2022 7:59 PM EST100$26.585

Fresenius Medical Care AG & Co. KGaA (FMS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1333141/000110465920077497/0001104659-20-077497-index.htm
2005-10-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000005053088/0000000000-05-053088-index.htm
2006-02-21UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000006008760/0000000000-06-008760-index.htm
2008-06-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000008027712/0000000000-08-027712-index.htm
2008-06-02UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1019600/000000000008027713/0000000000-08-027713-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1333141/000021545719008072/0000215457-19-008072-index.htm
2011-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1019600/000031506611002522/0000315066-11-002522-index.htm
2012-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1019600/000031506612002646/0000315066-12-002646-index.htm
2005-10-07F-4Registration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012305011984/0000950123-05-011984-index.htm
2005-10-11SC TO-ITender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012305012031/0000950123-05-012031-index.htm
2005-11-17F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012305013817/0000950123-05-013817-index.htm
2005-11-17SC TO-CWritten communication relating to an issuer or third partyhttps://www.sec.gov/Archives/edgar/data/1019600/000095012305013818/0000950123-05-013818-index.htm
2005-12-23F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012305015163/0000950123-05-015163-index.htm
2005-12-23SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012305015166/0000950123-05-015166-index.htm
2005-12-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1019600/000095012305015380/0000950123-05-015380-index.htm
2006-01-04F-4/ARegistration of securities, foreign private issuers, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000027/0000950123-06-000027-index.htm
2006-01-03CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000029/0000950123-06-000029-index.htm
2006-01-06424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1019600/000095012306000130/0000950123-06-000130-index.htm
2006-01-06SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000131/0000950123-06-000131-index.htm
2006-01-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1019600/000095012306000714/0000950123-06-000714-index.htm
2006-01-26SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012306000715/0000950123-06-000715-index.htm
2006-02-09SC TO-I/ATender offer statement by Issuerhttps://www.sec.gov/Archives/edgar/data/1019600/000095012306001370/0000950123-06-001370-index.htm
2005-07-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000791/0001019056-05-000791-index.htm
2005-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000840/0001019056-05-000840-index.htm
2005-08-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000931/0001019056-05-000931-index.htm
2005-08-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605000958/0001019056-05-000958-index.htm
2005-10-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001039/0001019056-05-001039-index.htm
2005-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001105/0001019056-05-001105-index.htm
2005-11-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001255/0001019056-05-001255-index.htm
2005-12-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001259/0001019056-05-001259-index.htm
2005-12-20425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000101905605001318/0001019056-05-001318-index.htm
2005-12-226-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001326/0001019056-05-001326-index.htm
2005-12-236-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905605001329/0001019056-05-001329-index.htm
2006-01-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000002/0001019056-06-000002-index.htm
2006-01-04425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1019600/000101905606000004/0001019056-06-000004-index.htm
2006-02-016-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000078/0001019056-06-000078-index.htm
2006-02-086-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000110/0001019056-06-000110-index.htm
2006-02-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000101905606000133/0001019056-06-000133-index.htm
2019-02-2020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1333141/000104746919000562/0001047469-19-000562-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746919002820/0001047469-19-002820-index.htm
2019-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746919004442/0001047469-19-004442-index.htm
2019-10-3120-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1333141/000104746919006012/0001047469-19-006012-index.htm
2019-10-316-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746919006013/0001047469-19-006013-index.htm
2020-02-2020-FAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1333141/000104746920000960/0001047469-20-000960-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746920002846/0001047469-20-002846-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746920004330/0001047469-20-004330-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000104746920005337/0001047469-20-005337-index.htm
2019-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919009478/0001104659-19-009478-index.htm
2019-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919009480/0001104659-19-009480-index.htm
2019-02-20IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1333141/000110465919009524/0001104659-19-009524-index.htm
2019-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919009728/0001104659-19-009728-index.htm
2019-02-266-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919010540/0001104659-19-010540-index.htm
2019-03-126-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919014180/0001104659-19-014180-index.htm
2019-04-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919019519/0001104659-19-019519-index.htm
2019-04-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919020567/0001104659-19-020567-index.htm
2019-04-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919024995/0001104659-19-024995-index.htm
2019-05-026-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919026308/0001104659-19-026308-index.htm
2019-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919030697/0001104659-19-030697-index.htm
2019-05-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919031908/0001104659-19-031908-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/1333141/000110465919033034/0001104659-19-033034-index.htm
2019-06-146-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919035489/0001104659-19-035489-index.htm
2019-06-186-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919036076/0001104659-19-036076-index.htm
2019-06-2711-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1333141/000110465919037864/0001104659-19-037864-index.htm
2019-07-116-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919039891/0001104659-19-039891-index.htm
2019-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919042505/0001104659-19-042505-index.htm
2019-08-286-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919047645/0001104659-19-047645-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919057169/0001104659-19-057169-index.htm
2019-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919057180/0001104659-19-057180-index.htm
2019-10-316-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919058403/0001104659-19-058403-index.htm
2019-10-316-K/AReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919058428/0001104659-19-058428-index.htm
2019-11-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465919066019/0001104659-19-066019-index.htm
2020-02-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920023065/0001104659-20-023065-index.htm
2020-02-20IRANNOTICENotice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Acthttps://www.sec.gov/Archives/edgar/data/1333141/000110465920023280/0001104659-20-023280-index.htm
2020-02-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920023628/0001104659-20-023628-index.htm
2020-05-066-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920057373/0001104659-20-057373-index.htm
2020-05-196-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920063458/0001104659-20-063458-index.htm
2020-05-206-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920064025/0001104659-20-064025-index.htm
2020-05-216-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920064587/0001104659-20-064587-index.htm
2020-05-29SDhttps://www.sec.gov/Archives/edgar/data/1333141/000110465920067320/0001104659-20-067320-index.htm
2020-06-2611-KAnnual report of employee stock purchase, savings and similar planshttps://www.sec.gov/Archives/edgar/data/1333141/000110465920077497/0001104659-20-077497-index.htm
2020-07-176-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920084339/0001104659-20-084339-index.htm
2020-07-306-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920088067/0001104659-20-088067-index.htm
2020-08-276-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920099294/0001104659-20-099294-index.htm
2020-09-106-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920103698/0001104659-20-103698-index.htm
2020-10-136-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920114053/0001104659-20-114053-index.htm
2020-10-296-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1333141/000110465920119245/0001104659-20-119245-index.htm
2005-08-056-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000132693205000058/0001326932-05-000058-index.htm
2005-11-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000132693205000107/0001326932-05-000107-index.htm
2006-05-036-KReport of foreign issuer [Rules 13a-16 and 15d-16]https://www.sec.gov/Archives/edgar/data/1019600/000132693206000162/0001326932-06-000162-index.htm